{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:18:00Z","timestamp":1790543880678,"version":"4.1.0"},"reference-count":53,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The use of peripheral blood stem cells (PBSCs) is rapidly growing in the allogeneic transplantation setting as an alternative to bone marrow (BM). We previously reported a higher incidence of chronic graft-versus-host disease (cGVHD) associated with allogeneic PBSC transplantation in a randomized trial. In this follow-up report, we analyzed the evolution of cGVHD in the patients (n\u2009=\u2009101) enrolled on this study. At a median follow-up of 45 months (range, 31-57 months), we found that the 3-year cumulative incidence of cGVHD was 65% (95% confidence interval [CI] 51%-78%) in the PBSC group and 36% (95% CI 23%-49%) in the BM group (P\u2009=\u2009.004). We also found that extensive cGVHD was more frequent in the PBSC group (44% [95% CI 30%-58%] vs 17% [95% CI 7%-27%];P\u2009=\u2009.004). The prevalence of cGVHD was always higher in the PBSC arm. Ocular involvement was more frequent in PBSC recipients (P\u2009=\u2009.02). Cutaneous and liver involvement was similar among BM and PBSC recipients. Chronic GVHD required multiple courses of immunosuppressive therapy in addition to cyclosporine and corticosteroids during longer periods (P\u2009=\u2009.03). Altogether, this translated into longer periods of hospitalization after transplantation in the PBSC group (P\u2009=\u2009.04). Finally, we also confirm that cGVHD after PBSC transplantation is associated with an antileukemic effect that is at least as potent as after BM. However, to date, this has not translated into a survival difference, possibly due to the early-stage leukemic status of these patients or to the relatively small size of the study population.<\/jats:p>","DOI":"10.1182\/blood.v100.9.3128","type":"journal-article","created":{"date-parts":[[2002,10,16]],"date-time":"2002-10-16T23:03:08Z","timestamp":1034809388000},"page":"3128-3134","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":158,"title":["Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study"],"prefix":"10.1182","volume":"100","author":[{"given":"Mohamad","family":"Mohty","sequence":"first","affiliation":[{"name":"From the Institut Paoli-Calmettes, Marseille, France; Centre Hospitalier Universitaire (CHU) Henri Mondor, Cre\u0301teil, France; CHU Edouard Herriot, Lyon, France; Institut Gustave Roussy, Villejuif, France; CHU Ho\u0302tel-Dieu, Nantes, France; CHU de la Pitie\u0301 Salpetrie\u0300re, Paris, France; CHU Huriez, Lille, France; CHU Purpan, Toulouse, France; CHU de Brabois, Nancy, France; CHU J. Minjoz, Besanc\u0327on, France; and CHU du Haut Leve\u0302que, Bordeaux, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Kuentz","sequence":"additional","affiliation":[{"name":"From the Institut Paoli-Calmettes, Marseille, France; Centre Hospitalier Universitaire (CHU) Henri Mondor, Cre\u0301teil, France; CHU Edouard Herriot, Lyon, France; Institut Gustave Roussy, Villejuif, France; CHU Ho\u0302tel-Dieu, Nantes, France; CHU de la Pitie\u0301 Salpetrie\u0300re, Paris, France; CHU Huriez, Lille, France; CHU Purpan, Toulouse, France; CHU de Brabois, Nancy, France; CHU J. Minjoz, Besanc\u0327on, France; and CHU du Haut Leve\u0302que, Bordeaux, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricette","family":"Michallet","sequence":"additional","affiliation":[{"name":"From the Institut Paoli-Calmettes, Marseille, France; Centre Hospitalier Universitaire (CHU) Henri Mondor, Cre\u0301teil, France; CHU Edouard Herriot, Lyon, France; Institut Gustave Roussy, Villejuif, France; CHU Ho\u0302tel-Dieu, Nantes, France; CHU de la Pitie\u0301 Salpetrie\u0300re, Paris, France; CHU Huriez, Lille, France; CHU Purpan, Toulouse, France; CHU de Brabois, Nancy, France; CHU J. Minjoz, Besanc\u0327on, France; and CHU du Haut Leve\u0302que, Bordeaux, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Henri","family":"Bourhis","sequence":"additional","affiliation":[{"name":"From the Institut Paoli-Calmettes, Marseille, France; Centre Hospitalier Universitaire (CHU) Henri Mondor, Cre\u0301teil, France; CHU Edouard Herriot, Lyon, France; Institut Gustave Roussy, Villejuif, France; CHU Ho\u0302tel-Dieu, Nantes, France; CHU de la Pitie\u0301 Salpetrie\u0300re, Paris, France; CHU Huriez, Lille, France; CHU Purpan, Toulouse, France; CHU de Brabois, Nancy, France; CHU J. Minjoz, Besanc\u0327on, France; and CHU du Haut Leve\u0302que, Bordeaux, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noe\u0308l","family":"Milpied","sequence":"additional","affiliation":[{"name":"From the Institut Paoli-Calmettes, Marseille, France; Centre Hospitalier Universitaire (CHU) Henri Mondor, Cre\u0301teil, France; CHU Edouard Herriot, Lyon, France; Institut Gustave Roussy, Villejuif, France; CHU Ho\u0302tel-Dieu, Nantes, France; CHU de la Pitie\u0301 Salpetrie\u0300re, Paris, France; CHU Huriez, Lille, France; CHU Purpan, Toulouse, France; CHU de Brabois, Nancy, France; CHU J. Minjoz, Besanc\u0327on, France; and CHU du Haut Leve\u0302que, Bordeaux, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Sutton","sequence":"additional","affiliation":[{"name":"From the Institut Paoli-Calmettes, Marseille, France; Centre Hospitalier Universitaire (CHU) Henri Mondor, Cre\u0301teil, France; CHU Edouard Herriot, Lyon, France; Institut Gustave Roussy, Villejuif, France; CHU Ho\u0302tel-Dieu, Nantes, France; CHU de la Pitie\u0301 Salpetrie\u0300re, Paris, France; CHU Huriez, Lille, France; CHU Purpan, Toulouse, France; CHU de Brabois, Nancy, France; CHU J. Minjoz, Besanc\u0327on, France; and CHU du Haut Leve\u0302que, Bordeaux, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Jouet","sequence":"additional","affiliation":[{"name":"From the Institut Paoli-Calmettes, Marseille, France; Centre Hospitalier Universitaire (CHU) Henri Mondor, Cre\u0301teil, France; CHU Edouard Herriot, Lyon, France; Institut Gustave Roussy, Villejuif, France; CHU Ho\u0302tel-Dieu, Nantes, France; CHU de la Pitie\u0301 Salpetrie\u0300re, Paris, France; CHU Huriez, Lille, France; CHU Purpan, Toulouse, France; CHU de Brabois, Nancy, France; CHU J. Minjoz, Besanc\u0327on, France; and CHU du Haut Leve\u0302que, Bordeaux, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Attal","sequence":"additional","affiliation":[{"name":"From the Institut Paoli-Calmettes, Marseille, France; Centre Hospitalier Universitaire (CHU) Henri Mondor, Cre\u0301teil, France; CHU Edouard Herriot, Lyon, France; Institut Gustave Roussy, Villejuif, France; CHU Ho\u0302tel-Dieu, Nantes, France; CHU de la Pitie\u0301 Salpetrie\u0300re, Paris, France; CHU Huriez, Lille, France; CHU Purpan, Toulouse, France; CHU de Brabois, Nancy, France; CHU J. Minjoz, Besanc\u0327on, France; and CHU du Haut Leve\u0302que, Bordeaux, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Bordigoni","sequence":"additional","affiliation":[{"name":"From the Institut Paoli-Calmettes, Marseille, France; Centre Hospitalier Universitaire (CHU) Henri Mondor, Cre\u0301teil, France; CHU Edouard Herriot, Lyon, France; Institut Gustave Roussy, Villejuif, France; CHU Ho\u0302tel-Dieu, Nantes, France; CHU de la Pitie\u0301 Salpetrie\u0300re, Paris, France; CHU Huriez, Lille, France; CHU Purpan, Toulouse, France; CHU de Brabois, Nancy, France; CHU J. Minjoz, Besanc\u0327on, France; and CHU du Haut Leve\u0302que, Bordeaux, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Cahn","sequence":"additional","affiliation":[{"name":"From the Institut Paoli-Calmettes, Marseille, France; Centre Hospitalier Universitaire (CHU) Henri Mondor, Cre\u0301teil, France; CHU Edouard Herriot, Lyon, France; Institut Gustave Roussy, Villejuif, France; CHU Ho\u0302tel-Dieu, Nantes, France; CHU de la Pitie\u0301 Salpetrie\u0300re, Paris, France; CHU Huriez, Lille, France; CHU Purpan, Toulouse, France; CHU de Brabois, Nancy, France; CHU J. Minjoz, Besanc\u0327on, France; and CHU du Haut Leve\u0302que, Bordeaux, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Boiron","sequence":"additional","affiliation":[{"name":"From the Institut Paoli-Calmettes, Marseille, France; Centre Hospitalier Universitaire (CHU) Henri Mondor, Cre\u0301teil, France; CHU Edouard Herriot, Lyon, France; Institut Gustave Roussy, Villejuif, France; CHU Ho\u0302tel-Dieu, Nantes, France; CHU de la Pitie\u0301 Salpetrie\u0300re, Paris, France; CHU Huriez, Lille, France; CHU Purpan, Toulouse, France; CHU de Brabois, Nancy, France; CHU J. Minjoz, Besanc\u0327on, France; and CHU du Haut Leve\u0302que, Bordeaux, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Blaise","sequence":"additional","affiliation":[{"name":"From the Institut Paoli-Calmettes, Marseille, France; Centre Hospitalier Universitaire (CHU) Henri Mondor, Cre\u0301teil, France; CHU Edouard Herriot, Lyon, France; Institut Gustave Roussy, Villejuif, France; CHU Ho\u0302tel-Dieu, Nantes, France; CHU de la Pitie\u0301 Salpetrie\u0300re, Paris, France; CHU Huriez, Lille, France; CHU Purpan, Toulouse, France; CHU de Brabois, Nancy, France; CHU J. Minjoz, Besanc\u0327on, France; and CHU du Haut Leve\u0302que, Bordeaux, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111616534500400_B1","first-page":"895","article-title":"Comparison of G-CSF-primed peripheral blood progenitor cells and bone marrow auto transplantation: clinical assessment and cost-effectiveness.","volume":"14","author":"Faucher","year":"1994","journal-title":"Bone Marrow Transplant."},{"key":"2019111616534500400_B2","doi-asserted-by":"crossref","first-page":"600","DOI":"10.7326\/0003-4819-126-8-199704150-00002","article-title":"Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trial.","volume":"126","author":"Hartmann","year":"1997","journal-title":"Ann Intern Med."},{"key":"2019111616534500400_B3","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1182\/blood.V85.6.1659.bloodjournal8561659","article-title":"Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts.","volume":"85","author":"Korbling","year":"1995","journal-title":"Blood."},{"key":"2019111616534500400_B4","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood.V85.6.1655.bloodjournal8561655","article-title":"Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor.","volume":"85","author":"Bensinger","year":"1995","journal-title":"Blood."},{"key":"2019111616534500400_B5","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood.V85.6.1666.bloodjournal8561666","article-title":"Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor).","volume":"85","author":"Schmitz","year":"1995","journal-title":"Blood."},{"key":"2019111616534500400_B6","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1182\/blood.V88.7.2794.bloodjournal8872794","article-title":"Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation.","volume":"88","author":"Bensinger","year":"1996","journal-title":"Blood."},{"key":"2019111616534500400_B7","first-page":"703","article-title":"Allogeneic blood cell transplants for haematological malignancy: preliminary comparison of outcomes with bone marrow transplantation.","volume":"17","author":"Russell","year":"1996","journal-title":"Bone Marrow Transplant."},{"key":"2019111616534500400_B8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.bmt.1700692","article-title":"Allogeneic blood stem cell transplantation in advanced hematologic cancers.","volume":"19","author":"Przepiorka","year":"1997","journal-title":"Bone Marrow Transplant."},{"key":"2019111616534500400_B9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.bmt.1700603","article-title":"Allogeneic peripheral blood stem cell transplantation for haematological malignancies\u2014an analysis of kinetics of engraftment and GVHD risk.","volume":"19","author":"Miflin","year":"1997","journal-title":"Bone Marrow Transplant."},{"key":"2019111616534500400_B10","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/sj.bmt.1701234","article-title":"Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation.","volume":"21","author":"Schmitz","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"2019111616534500400_B11","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/sj.bmt.1701510","article-title":"A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies.","volume":"22","author":"Vigorito","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"2019111616534500400_B12","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(00)02090-0","article-title":"Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial.","volume":"355","author":"Powles","year":"2000","journal-title":"Lancet."},{"key":"2019111616534500400_B13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.2000.18.3.537","article-title":"Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Societe Francaise de Greffe de Moelle.","volume":"18","author":"Blaise","year":"2000","journal-title":"J Clin Oncol."},{"key":"2019111616534500400_B14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJM200101183440303","article-title":"Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.","volume":"344","author":"Bensinger","year":"2001","journal-title":"N Engl J Med."},{"key":"2019111616534500400_B15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00062752-200011000-00004","article-title":"Bone marrow or peripheral blood as a source of stem cells for allogeneic transplants.","volume":"7","author":"Bacigalupo","year":"2000","journal-title":"Curr Opin Hematol."},{"key":"2019111616534500400_B16","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/sj.bmt.1702422","article-title":"A randomised study of allogeneic transplantation with stem cells from blood or bone marrow.","volume":"25","author":"Heldal","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"2019111616534500400_B17","first-page":"481a","article-title":"A randomised study from the European group for blood and marrow transplantation comparing allogeneic transplantation of Filgrastim-mobilised peripheral blood progenitor cells with bone marrow transplantation in 350 patients (pts) with leukemia [abstract].","volume":"96","author":"Schmitz","year":"2000","journal-title":"Blood."},{"key":"2019111616534500400_B18","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1182\/blood.V98.10.2900","article-title":"Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?","volume":"98","author":"Korbling","year":"2001","journal-title":"Blood."},{"key":"2019111616534500400_B19","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJM198603203141201","article-title":"Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia.","volume":"314","author":"Storb","year":"1986","journal-title":"N Engl J Med."},{"key":"2019111616534500400_B20","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJM197504242921706","article-title":"Bone-marrow transplantation (second of two parts).","volume":"292","author":"Thomas","year":"1975","journal-title":"N Engl J Med."},{"key":"2019111616534500400_B21","first-page":"3702","article-title":"Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).","volume":"95","author":"Champlin","year":"2000","journal-title":"Blood."},{"key":"2019111616534500400_B22","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1182\/blood.V98.6.1695","article-title":"Chronic graft-versus-host disease after allogeneic blood stem cell transplantation.","volume":"98","author":"Przepiorka","year":"2001","journal-title":"Blood."},{"key":"2019111616534500400_B23","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1182\/blood.V98.12.3221","article-title":"CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation.","volume":"98","author":"Zaucha","year":"2001","journal-title":"Blood."},{"key":"2019111616534500400_B24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med."},{"key":"2019111616534500400_B25","first-page":"173","article-title":"The histopathology of graft-versus-host disease.","volume":"1","author":"Farmer","year":"1986","journal-title":"Adv Dermatol."},{"key":"2019111616534500400_B26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood.V57.2.267.bloodjournal572267","article-title":"Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression.","volume":"57","author":"Sullivan","year":"1981","journal-title":"Blood."},{"key":"2019111616534500400_B27","first-page":"250","article-title":"Chronic graft-versus-host disease and other late complications of bone marrow transplantation.","volume":"28","author":"Sullivan","year":"1991","journal-title":"Semin Hematol."},{"key":"2019111616534500400_B28","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1079-2104(96)80203-4","article-title":"Oral involvement in chronic graft-versus-host disease after allogeneic bone marrow transplantation.","volume":"82","author":"Nakamura","year":"1996","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod."},{"key":"2019111616534500400_B29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00004397-199703720-00010","article-title":"The ocular manifestations of graft-versus-host disease.","volume":"37","author":"Johnson","year":"1997","journal-title":"Int Ophthalmol Clin."},{"key":"2019111616534500400_B30","first-page":"425","article-title":"Gynecological abnormalities following allogeneic bone marrow transplantation.","volume":"5","author":"Schubert","year":"1990","journal-title":"Bone Marrow Transplant."},{"key":"2019111616534500400_B31","doi-asserted-by":"crossref","first-page":"368","DOI":"10.7326\/0003-4819-111-5-368","article-title":"Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course.","volume":"111","author":"Clark","year":"1989","journal-title":"Ann Intern Med."},{"key":"2019111616534500400_B32","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/0016-5085(81)90059-7","article-title":"Esophageal abnormalities in chronic graft-versus-host disease in humans.","volume":"80","author":"McDonald","year":"1981","journal-title":"Gastroenterology."},{"key":"2019111616534500400_B33","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1212\/WNL.33.9.1222","article-title":"Myositis of chronic graft-versus-host disease.","volume":"33","author":"Reyes","year":"1983","journal-title":"Neurology."},{"key":"2019111616534500400_B34","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO;2-W","article-title":"The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting.","volume":"53","author":"Mor","year":"1984","journal-title":"Cancer."},{"key":"2019111616534500400_B35","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/oxfordjournals.aje.a112220","article-title":"Estimability and estimation in case-referent studies.","volume":"103","author":"Miettinen","year":"1976","journal-title":"Am J Epidemiol."},{"key":"2019111616534500400_B36","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med."},{"key":"2019111616534500400_B37","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1365-2141.1993.tb04697.x","article-title":"Summarizing data on survival, relapse, and chronic graft-versus-host disease after bone marrow transplantation: motivation for and description of new methods.","volume":"83","author":"Pepe","year":"1993","journal-title":"Br J Haematol."},{"key":"2019111616534500400_B38","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations.","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc."},{"key":"2019111616534500400_B39","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0021-9681(78)90043-7","article-title":"Estimation of confidence limits for the cumulative probability of survival in life table analysis.","volume":"31","author":"Rothman","year":"1978","journal-title":"J Chronic Dis."},{"key":"2019111616534500400_B40","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease.","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst."},{"key":"2019111616534500400_B41","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1200\/JCO.1983.1.11.710","article-title":"Analysis of survival by tumor response.","volume":"1","author":"Anderson","year":"1983","journal-title":"J Clin Oncol."},{"key":"2019111616534500400_B42","first-page":"69","article-title":"Chronic graft-versus-host disease.","volume":"5","author":"Atkinson","year":"1990","journal-title":"Bone Marrow Transplant."},{"key":"2019111616534500400_B43","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1182\/blood.V80.7.1838.1838","article-title":"Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate.","volume":"80","author":"Nash","year":"1992","journal-title":"Blood."},{"key":"2019111616534500400_B44","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM200105243442114","article-title":"Hematopoietic reconstitution by transplantation of stem cells from bone marrow or blood.","volume":"344","author":"Bensinger","year":"2001","journal-title":"N Engl J Med."},{"key":"2019111616534500400_B45","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1182\/blood.V97.8.2514","article-title":"Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants.","volume":"97","author":"Volpi","year":"2001","journal-title":"Blood."},{"key":"2019111616534500400_B46","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1182\/blood.V87.2.574.bloodjournal872574","article-title":"CD14+ cells in granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood mononuclear cells induce secretion of interleukin-6 and G-CSF by marrow stroma.","volume":"87","author":"Mielcarek","year":"1996","journal-title":"Blood."},{"key":"2019111616534500400_B47","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood.V95.8.2484","article-title":"Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells.","volume":"95","author":"Arpinati","year":"2000","journal-title":"Blood."},{"key":"2019111616534500400_B48","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1182\/blood.V86.12.4422.bloodjournal86124422","article-title":"Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease.","volume":"86","author":"Pan","year":"1995","journal-title":"Blood."},{"key":"2019111616534500400_B49","first-page":"101","article-title":"Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation.","volume":"17","author":"Talmadge","year":"1996","journal-title":"Bone Marrow Transplant."},{"key":"2019111616534500400_B50","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.4049\/jimmunol.124.4.1808","article-title":"In vitro tests correlating with presence or absence of graft-vs-host disease in DLA nonidentical canine radiation chimeras: evidence that clonal abortion maintains stable graft-host tolerance.","volume":"124","author":"Atkinson","year":"1980","journal-title":"J Immunol."},{"key":"2019111616534500400_B51","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation.","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood."},{"key":"2019111616534500400_B52","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood.V87.1.386.386","article-title":"Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients.","volume":"87","author":"Deeg","year":"1996","journal-title":"Blood."},{"key":"2019111616534500400_B53","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1182\/blood.V97.11.3669","article-title":"Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission.","volume":"97","author":"Blaise","year":"2001","journal-title":"Blood."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/9\/3128\/1257158\/h82102003128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/9\/3128\/1257158\/h82102003128.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T23:13:30Z","timestamp":1682378010000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/100\/9\/3128\/16375\/Chronic-graftversushost-disease-after-allogeneic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11,1]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2002,11,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v100.9.3128","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,11,1]]}}}